In May 2019, a trial at Nanjing College Healthcare facility began comparing dapagliflozin to liraglutide, and also to the anti-diabetic medication acarbose, for his or her respective effects on cognitive and olfactory purpose in 87 overweight folks whose Form two diabetes is badly controlled with metformin on your own. [three] https://henryv009htd2.wikitron.com/user